Revisiting the Strategies for the Pharmacological Management of Type 2 Diabetes- from Glycemic Control, Organ Protection, Safety to Weight Reduction.

The goals of diabetes care are to prevent complications and optimize quality of life. Based on the goals, several strategies have developed and are still evolving for the pharmacological management of type 2 diabetes. In the last decade, various new anti-diabetic drugs have been developed, including dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and several insulin analogues.